Vical, Inc. (NASDAQ:VICL)

CAPS Rating: 3 out of 5

The Company researches and develops biopharmaceutical products based on its patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases.

Recs

0
Player Avatar portefeuille (99.75) Submitted: 11/25/2010 2:49:39 PM : Outperform Start Price: $3.10 VICL Score: -31.37

currently 350 shares in my portfolio.

Report this Post 1 Comment
Member Avatar portefeuille (99.75) Submitted: 1/22/2011 6:05:53 PM
Recs: 0

I no longer update my portfolio positions.

Featured Broker Partners


Advertisement